🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
To assess the safety, tolerability and pharmacokinetics of ABT-199 in femal...
Status
Completed
Location
Site Reference ID/Investigator# 89694
Start Date
2012-11
Trial ID
NCT01686555
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This is a First in Human (FIH), double-blinded, parallel-group, randomised,...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2019-07-03
Trial ID
NCT04036227
The principal aim of this study is to obtain safety and tolerability data w...
Status
Active Not Recruiting
Location
Clinical Pharmacology of Miami, LLC
Start Date
2025-06-27
Trial ID
NCT07119125
The primary purpose of this study is to assess the safety and tolerability ...
Status
Completed
Location
ICON 1255 East 3900 South
Start Date
2024-02-20
Trial ID
NCT06286033
The purpose of this study is to evaluate the safety, tolerability, and drug...
Status
Completed
Location
ICON Plc (PRA Health Sciences) - Netherlands
Start Date
2020-09-17
Trial ID
NCT04550195
Treatments Being Tested